All stock lists
GeneDx Holdings Corp. (NASDAQ:WGS)
US · Delayed Price · Currency is USD
Healthcare · Medical - Diagnostics & Research
62.63
Insider Score
––Not scored
WGS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
WGS analyst forecast
WGS analyst consensus
Moderate Buy3 ratings
Buy 3 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
WGS 12-month price target
No published price targets in the last 12 months.
Best analysts covering WGS
- BTIG67%success rate · 6 calls
- Piper Sandler0%success rate · 2 calls
- Guggenheim0%success rate · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
WGS analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Guggenheim | Buy | — | — | Reiterated | 2026-10-01 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-08-04 |
| — | BTIG | Buy | — | — | Reiterated | 2026-08-04 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-06-29 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-06-23 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-05-05 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-05-05 |
| — | BTIG | Buy | — | — | Reiterated | 2026-05-05 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-05-05 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-04-20 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-03-30 |
| — | BTIG | Buy | — | — | Reiterated | 2026-02-24 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-02-24 |
| — | Wells Fargo | Overweight | — | — | Upgraded | 2026-02-09 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-12-22 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-12-15 |
| — | BTIG | Buy | — | — | Reiterated | 2025-12-12 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-11-04 |
| — | BTIG | Buy | — | — | Reiterated | 2025-10-29 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-10-29 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-10-29 |
| — | BTIG | Buy | — | — | Reiterated | 2025-10-22 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-09-11 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-08-04 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-07-30 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-06-30 |
| — | Jefferies | Buy | — | — | Upgraded | 2025-05-09 |
| — | TD Securities | Buy | — | — | Reiterated | 2025-05-01 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-05-01 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2025-02-19 |
| — | TD Cowen | Buy | — | — | Reiterated | 2025-01-07 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2024-10-30 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2024-10-30 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2024-10-30 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2024-10-24 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2024-10-16 |
| — | TD Cowen | Buy | — | — | Reiterated | 2024-07-31 |
| — | BTIG | Buy | — | — | Reiterated | 2024-07-31 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2024-07-31 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2024-07-31 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2024-07-17 |
| — | BTIG | Buy | — | — | Reiterated | 2024-06-26 |
| — | TD Cowen | Buy | — | — | Reiterated | 2024-04-30 |
| — | BTIG | Buy | — | — | Reiterated | 2024-04-30 |
| — | BTIG | Buy | — | — | Reiterated | 2024-04-22 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2024-04-15 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2023-11-01 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2023-08-09 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2023-07-24 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2023-07-21 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2023-05-15 |
| — | Goldman Sachs | Neutral | — | — | Downgraded | 2022-12-07 |
| — | Cowen & Co. | Outperform | — | — | Reiterated | 2022-11-15 |
| — | BTIG | Buy | — | — | Reiterated | 2022-08-18 |
| — | Jefferies | Hold | — | — | Downgraded | 2022-08-16 |
WGS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-23 | 0.11 | 0.14 | $120.3M | $121.0M |
| 2026-05-04 | -0.06 | -0.28 | $112.5M | $102.3M |
| 2026-08-03 | -0.19 | 0.01 | $111.0M | $114.4M |
| 2026-11-03 | 0.07 | 0.00 | $122.9M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.